Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biologics
Biotech
Novo calls off $598M Heartseed collab, citing 'strategic reviews'
Japanese biotech Heartseed said it was "difficult to reasonably foresee" that Novo would scrap the 2021 deal, despite the pharma's restructuring.
Zoey Becker
Sep 30, 2025 1:55pm
Opus sets sights on FDA talks after posting gene therapy data
Sep 30, 2025 9:15am
Biogen discontinues all AAV gene therapy work
Sep 26, 2025 11:04am
Merck opts in on Evaxian's preclinical vaccine candidate
Sep 25, 2025 7:00am
uniQure plans FDA push after Huntington's gene therapy trial win
Sep 24, 2025 9:20am
Fierce Pharma
RFK Jr.'s ACIP delivers perplexing vote on MMRV vaccine guidance
Sep 18, 2025 6:33pm
